Medical Journals

The Escherichia Coli Pria Helicase Has Two Nucleotide-binding Sites Differing Dramatically in Their Affinities for Nucleotide Cofactors. 1. Intrinsic Affinities, Cooperativities, and Base Specificity of Nucleotide Cofactor Binding.

Authors:
  • Lucius Aaron L
  • Jezewska Maria J
  • Bujalowski Wlodzimierz

From: Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, Texas 77555-1053, USA.

Biochemistry

  • Publish Date: Jun 2006
  • ISSN: 0006-2960
  • Volume: 45
  • Issue: 23
  • Pages: 7202-16
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lucius Aaron L, Jezewska Maria J, Bujalowski Wlodzimierz, et al. The Escherichia Coli Pria Helicase Has Two Nucleotide-binding Sites Differing Dramatically in Their Affinities for Nucleotide Cofactors. 1. Intrinsic Affinities, Cooperativities, and Base Specificity of Nucleotide Cofactor Binding.. Biochemistry Jun 2006;45:7202-16

Abstract

Interactions of the Escherichia coli PriA helicase with nucleotide cofactors have been studied using the fluorescence titration and analytical ultracentrifugation techniques. Binding of unmodified cofactors was characterized by the fluorescence competition titration method. The obtained data establish that at saturation the PriA helicase binds two nucleotide molecules per protein monomer. This result corroborates with the primary structure of the protein, which contains sequence motifs implicated as putative nucleotide-binding sites. The intrinsic affinities of the binding sites differ by 2-4 orders of magnitude. Thus, the PriA helicase has a strong and a weak nucleotide-binding site. The binding sites differ dramatically in their properties. The strong site is highly specific for adenosine cofactors, while the weak site shows very modest base specificity. The affinities of the strong and weak binding sites for ATP are lower than the affinities for ADP, although both sites have similar affinity for the inorganic phosphate group. Unlike the weak site, the affinity of the strong site profoundly depends on the structure of the phosphate group of the ATP cofactor. Binding of unmodified nucleotides indicates the presence of positive cooperative interactions between bound cofactors (i.e., the existence of communication between the two sites). Magnesium cations are specifically involved in controlling the cofactor affinity for the strong site, while the affinity of the weak site is predominantly determined by interactions between the phosphate group and ribose regions of the cofactor and the protein matrix. The significance of these results for the activities of the PriA helicase is discussed.

Mesh Headings (Keywords): Adenosine Diphosphate, Adenosine Triphosphatases, Adenosine Triphosphate, Binding Sites, DNA Helicases, Escherichia coli, Escherichia coli Proteins, Ligands, Spectrometry, Fluorescence


Check for Full Text / PubMed Unique Identifier (PMID): 16752911


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.